Review focus on epigenetics and the histone code in vascular biology

Cardiovascular Research

Volumn 90, Issue 3, 2011, Pages 402-403

  Ylä Herttuala, Seppo ^a,b   Glass, Christopher K ^c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MIGRATION; EDITORIAL; ENDOTHELIUM CELL; EPIGENETICS; HEART MUSCLE CELL; HISTONE ACETYLATION; HISTONE CODE; PRIORITY JOURNAL; VASCULAR BIOLOGY;

ANIMALS; BLOOD VESSELS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HISTONES; HUMANS; VASCULAR DISEASES;

EID: 79957438658     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr119     Document Type: Editorial

References (12)

1. Bird A. Perceptions of epigenetics. Nature 2007;447:396-398. (Pubitemid 46816744)
2. Turunen M, Aavik E, Ylä-Herttuala S. Epigenetics and atherosclerosis. BBA 2009;1790: 886-891.
3. Hiltunen MO, Turunen MP, Häkkinen TP, Rutanen J, Hedman M, Mäkinen K et al. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc Med 2002;7:5-11. (Pubitemid 34654067)
4. Turunen MP, Lehtola T, Heinonen SE, Assefa GS, Korpisalo P, Girnary R et al. Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism. A novel example of epigenetherapy. Circ Res 2009;105:604-609.
5. Ohtani K, Dimmeler S. Epigenetic regulation of cardiovascular differentiation. Cardiovasc Res 2011;90:404-412.
6. Zhou B, Margariti A, Zeng L, Xu Q. Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis. Cardiovasc Res 2011;90:413-420.
7. Reddy MA, Natarajan R. Epigenetic mechanisms in diabetic vascular complications. Cardiovasc Res 2011;90:421-429.
8. Kaikkonen MU, Lam MTY, Glass CK. Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc Res 2011;90:430-440.
9. Turunen MP, Ylä-Herttuala S. Epigenetic regulation of key vascular genes and growth factors. Cardiovasc Res 2011;90:441-446.
10. Illi B, Colussi C, Rosati J, Spallotta F, Nanni S, Farsetti A et al. NO points to epigenetics in vascular development. Cardiovasc Res 2011;90:447-456.
11. Dunoyer-Geindre S, Kruithof EKO. Epigenetic control of tissue-type plasminogen activator synthesis in human endothelial cells. Cardiovasc Res 2011;90:457-463.
12. Yu K, Zheng B, Han M, Wen J. ATRA activates and PDGF-BB represses the SM22a promoter through KLF4 binding to, or dissociating from, its cis-DNA elements. Cardiovasc Res 2011;90:464-474.